Search Results 371-380 of 17372 for oligomenorrhea
A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer.
Fuel groundbreaking medical research! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & ...
cc-mobile-stem-cell-research_mobile · National Doctors' Day is March 30! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers.
About this study. New studies are revealing how a high-fat diet could be making the cells of the intestinal lining more likely to become cancerous.
afp-lindsay-lehman · There's still time! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients.
Learn more about our world-class Moyamoya neurosurgeons located in Minnesota, Arizona and Florida, and read their research and publications on the subject.
About this study. RATIONALE: Interferon alfa may interfere with the growth of cancer cells. It is not yet known whether treatment with interferon alfa is ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20129674.
The purpose of this study is to evaluate EUS-nCLE as an imaging biomarker and PCL fluid DNA analysis as a molecular biomarker for the management of pancreatic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!